Aravive, Inc. Common Stock
ARAV
ARAV was delisted on the 26th of January, 2024.
32 hedge funds and large institutions have $20.1M invested in Aravive, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 11 increasing their positions, 3 reducing their positions, and 4 closing their positions.
601% more call options, than puts
Call options by funds: $505K | Put options by funds: $72K
521% more capital invested
Capital invested by funds: $3.24M → $20.1M (+$16.9M)
267% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 3
125% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 4
14% more funds holding
Funds holding: 28 → 32 (+4)
Top Buyers
| 1 |
BI
BVF Inc
San Francisco,
California
|
+$6.11M |
| 2 |
AG
Artal Group
Luxembourg
|
+$4.16M |
| 3 |
BBA
Baker Bros. Advisors
New York
|
+$4.16M |
| 4 |
Two Sigma Investments
New York
|
+$162K |
| 5 |
Two Sigma Advisers
New York
|
+$65.2K |
Top Sellers
ARAV Hedge Fund Activity: Q4 2022 in Review
32 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Aravive, Inc. Common Stock (ARAV) for Q4 2022, worth a combined $20.1M — up 521% from $3.24M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new ARAV positions and 4 closed out — a net gain of 5 holders — while 11 added to existing stakes and 3 trimmed.
The largest buyer was BVF Inc, opening a new position worth an estimated $6.11M. The largest seller was Renaissance Technologies, cutting an estimated $246K.
- 32 institutional investors held Aravive, Inc. Common Stock (ARAV) as of Q4 2022, up from 28 in Q3 2022.
- Funds reported $20.1M of Aravive, Inc. Common Stock stock for Q4 2022, up 521% quarter-over-quarter.
- 9 funds opened new Aravive, Inc. Common Stock positions in Q4 2022 and 4 closed out, a net change of +5 holders.
- The largest Aravive, Inc. Common Stock buyer in Q4 2022 was BVF Inc, an estimated $6.11M added.
- The largest Aravive, Inc. Common Stock seller in Q4 2022 was Renaissance Technologies, an estimated $246K sold.
Based on aggregated 13F filings for Q4 2022.